This trial is testing a new combination of drugs to see if it's more effective than standard treatment for T-cell lymphomas.
1 Primary · 5 Secondary · Reporting Duration: Up to 2 years
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Parsaclisib · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: